201000726 FoM Weekly Announcements and Opportunties

In this week’s issue:

Funding Opportunities:

· Alliance for Cancer Gene Therapy – 2011 Young Investigator Award Research Grant

· American Health Assistance Foundation – National Glaucoma Research Grants

· Bill and Melinda Gates Foundation – Grand Challenges Explorations, Round 8

Awards and Honours:

· March of Dimes Foundation – Prize in Developmental Biology


Alliance for Cancer Gene Therapy – 2011 Young Investigator Award Research Grant

LOI Deadline: September 1, 2011

Application Deadline: October 13, 2011

The overall objectives of this grant are to advance cell and gene therapy into the causes, treatment and prevention of all types of cancer by promoting development of novel and innovative studies by young investigators (Tenure Track Assistant Professor level). The emphasis of this initiative is to promote basic and pre-clinical research approaches utilizing cells and genes as medicine. ACGT will direct its grants into areas of cell and gene therapy research that have demonstrated great promise. The seven main areas of research ACGT will support are:

1. Tumor-Specific Replicating Viruses and Bacteria

2. Anti-angiogenesis

3. Immune-modulatory Therapy and Cancer Vaccines

4. Oncogene/Suppressor Oncogene/Apoptosis Directed Therapy

5. Tumor Targeting and Vector Development

6. Cancer Stem Cell Directed Therapy

7. Other Gene/Cell based Therapies

For more information please click on the link above.

American Health Assistance Foundation – National Glaucoma Research Grants

Deadline: October 26, 2011

AHAF provides research funds for U.S. domestic as well as international researchers. Grants are awarded on the basis of scientific merit and relevance of the research to understanding aspects of Glaucoma that lead to improved treatments, prevention strategies, and diagnoses. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Recipients range from junior investigators to more established investigators who are proposing particularly innovative research or attempting to enter the Glaucoma disease field.

AHAF’s funding mechanism for early stage glaucoma research has a maximum award value of US $100,000, payable over 2 years.

Bill and Melinda Gates Foundation – Grand Challenges Explorations, Round 8

Deadline: November 17, 2011

The Bill & Melinda Gates Foundation is now accepting grant proposals for Round 8 of Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions. Applicants can be at any experience level; in any discipline; and from any organization, including colleges and universities, government laboratories, research institutions, non-profit organizations and for profit companies.

Grant proposals are being accepted online until November 17, 2011 on the following topics:

NEW – Protect Crop Plants from Biotic Stresses From Field to Market

NEW – Design new approaches to optimize immunization systems

NEW – Explore New Solutions in Global Health Priority Areas

Explore Nutrition for Healthy Growth of Infants and Children

Apply Synthetic Biology to Global Health Challenges

Initial grants will be US $100,000 each, and projects showing promise will have the opportunity to receive additional funding of up to US $1 million.


March of Dimes Prize in Developmental Biology

Deadline: September 15, 2011

The March of Dimes Prize in Developmental Biology, a cash award of $250,000 and a silver medal, is awarded to investigators whose research has profoundly advanced the science that underlies our understanding of birth defects. For more information please see the attachment. If you would like to submit a nomination please contact Adrienne Hammond at adrienne.hammond@ubc.ca to obtain the appropriate forms.